9 Aug 2023

Bitter pill: New report finds NZ lags behind in timely access to medicines

From Nine To Noon, 9:05 am on 9 August 2023

A new report examining how medicines are funded in New Zealand suggests it's too cost-focused and should instead be approached as an investment in Kiwis' welfare.

The ShawView report - commissioned by Johnson&Johnson -  says New Zealand is falling behind similar high-income OECD countries in providing access to new treatments.

It suggests immediately funding the 109 medicines sitting on Pharmac's Options for Investment List, the creation of a government plan to increase the annual medicines budget to get it closer to the OECD average, developing new financing mechanisms, setting up a dedicated fund to finance innovative new medicines and creating a national medicine policy.

Brendan Shaw is behind the report - he's worked in a number of roles across government, NGOs and pharmaceutical associations - including Medicines Australia and with the International Federation of Pharmaceutical Manufacturers and Associations.

hand with pills

Photo: RNZ